On June 27, 2025, Insight Molecular Diagnostics Inc. held its annual shareholder meeting, with 73.46% of shares present, where shareholders elected four directors and ratified the appointment of the accounting firm CBIZ CPAs, among other proposals related to executive compensation and equity incentives.